Contact Us | Directions | Referring a Patient

A leading comprehensive brain tumor program, using molecular diagnostic, gene expression analysis,
cutting edge clinical trials and advanced medical informatics to customize treatment plans for cancer patients.
 Latest Headlines
Boy,7, fighting rare brain tumor gets support from strangers
Sun, 19 Feb 2017 11:53:05 GMT (ABC27)
Brain tumor triggers woman's sudden 'hyper-religious' behavior | Fox ...
Thu, 16 Feb 2017 14:44:57 GMT (Fox News)
Genomic analysis of brain tumor helps doctors keep cancer at bay ...
Sun, 19 Feb 2017 02:28:27 GMT (News)
Superheroes show up to help boy with brain tumor in Waterloo
Sun, 19 Feb 2017 16:33:53 GMT (KCCI Des Moines)
Yale: Analysis of brain tumor prolongs woman's life
Wed, 15 Feb 2017 18:44:21 GMT (Connecticut Post)
After brain tumor, Matt Tifft welcomes 'different chapter'
Fri, 17 Feb 2017 23:15:34 GMT (Artesia Daily Press)
Targeted radiosurgery better than whole-brain radiation for treating ...
Thu, 16 Feb 2017 20:52:23 GMT (Science Daily)
Brain tumor triggers visions of Virgin Mary & hyper-religiosity for ...
Fri, 17 Feb 2017 16:03:00 GMT (RT)
A young boy, a devastating brain tumor and parents who 'will do ...
Mon, 06 Feb 2017 23:01:30 GMT (Washington Post)
Metastatic Brain Tumor
Fri, 17 Feb 2017 15:34:26 GMT (Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017)
2/19/2017 5:14:14 PM
Feed cached:2/19/2017 5:35:36 PM

* Headlines are from industry sponsored news wires, medical journals and established news organizations from around the world . Please consider the source of the content when viewing the story.
  
 
17th Annual UCLA Brain Tumor Conference
March 10-11, 2017



• Register for the FREE Conference

• Download printable flyer and directions.

Join brain tumor survivors, family members, friends and health care professionals at the 17th Annual Brain Tumor Conference, hosted by the UCLA Brain Tumor Center. This conference will offer participants the opportunity to hear leading healthcare professionals speak about the latest treatments for brain tumors. Attendees will also have a chance to learn about symptom management, community resources and social support. Representatives from brain tumor organizations, health advocacy agencies, and support groups will also be available to offer vital information and resources catering to the brain tumor community.


Dani Saleh Brain Cancer Research Fund at UCLA


The Dani Saleh Brain Cancer Research Fund supports the brain cancer research collaboration between Dr. Timothy Cloughesy and Dr. Stan Nelson. This fund will directly support the work and training of a research fellow in Dr. Stan Nelson’s lab.

Dr. Nelson is Professor and Vice Chair of Human Genetics and Professor of Psychiatry at the David Geffen School of Medicine at UCLA.

Most Popular
. Clinical Trials
. Probe Set Analyzer
. Our Team
. Brain Tumor Translational Resource
. Art of the Brain
. Personalized Medicine using Targeted Molecular Therapy
. Online Giving
. How our Glioblastoma Multiforme Patients Perform
Neuro-Oncology on Facebook

Spring/Summer 2014
UCLA Neuro-Oncology : Breakthroughs Spotlighting new discovery in brain cancer research.



It is time to include patients with brain tumors in phase I trials in oncology.
J Clin Oncol.


Graded functional diffusion map-defined characteristics of apparent diffusion coefficients predict overall survival in recurrent glioblastoma treated with bevacizumab.
Neuro Oncol.


Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma.
Neuro Oncol.


Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment delivery.
J Neurooncol.


Phase II study of aflibercept in recurrent malignant glioma: a north american brain tumor consortium study.
J Clin Oncol.



All Information content hearof is designed for educational purposes only and is not for the purpose of rendering medical advice or professional services. The information provided should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. Any specific questions you may have regarding an individual's medical condition should be directed to the individual's primary care physician or other attending physician. In addition, if you have or suspect you may have a health problem, you should consult your health care provider.

Portions Copyright (Search, Chart, Content Publishing Tools, Photography, ProviderIQ) 1998-2017 SiliconMED North America

ProviderIQ is a registered trademark of SiliconMED North America and used by permission.

Copyright © 2017 UCLA Neuro-Oncology Program | Timothly Cloughesy MD; Director
All Rights Reserved.

[Content Published:2/19/2017 5:35:36 PM PST]